2013 Concentrates Data Epilepsy 
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Data collection. Palliative care indications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healer
JANUARY 17, 2022
While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. CBGA in a mouse model of epilepsy. 2013): 1306-1316. [5] 1988): 361-371. [4]
Healer
JANUARY 17, 2022
While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. CBGA in a mouse model of epilepsy. 2013): 1306-1316. [5] 1988): 361-371. [4]
Green Relief
MAY 13, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. It is the most commonly identified cause of epilepsy among adults. CB1 receptors are concentrated in the mammalian brain and central nervous system. But the U.S. BY MARTIN A.
Green Relief
MAY 12, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. It is the most commonly identified cause of epilepsy among adults. CB1 receptors are concentrated in the mammalian brain and central nervous system. But the U.S. BY MARTIN A.
Healer
JUNE 28, 2019
METHODS: We performed a systematic review of medical marijuana (1948-November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. Oral cannabinoids are of unknown efficacy in non-chorea-related symptoms of Huntington disease, Tourette syndrome, cervical dystonia, and epilepsy.
Expert insights. Personalized for you.
122 
Let's personalize your content